McKesson Corp MCK:NYSE

Last Price$142.27NYSE Previous Close - Last Trade as of 6:30PM ET 12/06/19
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$133.90 (10)
Ask (Size)$145.00 (3)
Day Low / HighN/A - N/A
Volume1.4 M
 

View Medical Distributors IndustryPeer Comparison as of 12/06/2019

 

McKesson Corp ( NYSE )

Price: $142.27
Change: +1.66 (1.18%)
Volume: 1.4 M
6:30PM ET 12/06/2019
 
 

AmerisourceBergen Corp ( NYSE )

Price: $88.24
Change: +0.42 (0.48%)
Volume: 728.4 K
6:30PM ET 12/06/2019
 
 

Cardinal Health Inc ( NYSE )

Price: $54.87
Change: +0.62 (1.14%)
Volume: 1.5 M
6:30PM ET 12/06/2019
 
 

Henry Schein Inc ( NASDAQ )

Price: $69.42
Change: +0.25 (0.36%)
Volume: 903.7 K
4:00PM ET 12/06/2019
 
 

Patterson Companies Inc ( NASDAQ )

Price: $23.51
Change: +0.41 (1.77%)
Volume: 2.1 M
4:00PM ET 12/06/2019
 

Read more news Recent News

Market Chatter: Federal Prosecutors Reportedly Open Probe of Opioid Makers, Distributors
3:47PM ET 11/26/2019 MT Newswires

Shares of opiod makers and distributors slumped in afternoon trade after the WSJ said federal prosecutors have opened a criminal probe into the role of...

Opioid Makers, Distributors Shares Skid Lower on Federal Criminal Probe Report as Fitch Sees 'Headline Risk'
3:13PM ET 11/26/2019 MT Newswires

Shares of drug-related companies skidded lower on Tuesday amid a report of a possible federal criminal investigation into opioids, while Fitch Ratings said...

AdaptHealth to Buy McKesson's Patient Care Solutions Business for Undisclosed Sum
9:28AM ET 11/22/2019 MT Newswires

Home medical equipment provider AdaptHealth (AHCO) said Friday that it signed a definitive deal to acquire McKesson's (MCK) patient case solutions (PCS)...

Analysts Scale Back McKesson's Q1, 2020, and 2021 Earnings Outlook
5:56AM ET 11/01/2019 MT Newswires

Consensus forecasts for McKesson Corp's (NYSE:MCK, Recent Price: 136.79) Q1 ending December 31, 2019, and the full year estimates for 2020 and 2021 have...

Company Profile

Business DescriptionMcKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX. View company web site for more details
Address6555 State Highway 161
Irving, Texas 75039
Phone+1.972.446.4800
Number of Employees80,000
Recent SEC Filing11/05/20194
Chief Executive Officer & DirectorBrian Scott Tyler
Chief Financial Officer & Executive Vice PresidentBritt Vitalone
Chief Technology & Information Officer, EVPKathy McElligott
Chief Compliance Officer, EVP & General CounselLori A. Schechter

Company Highlights

Price Open$141.74
Previous Close$140.61
52 Week Range$106.11 - 154.79
Market Capitalization$25.6 B
Shares Outstanding180.2 M
SectorDistribution Services
IndustryMedical Distributors
Current Dividend / Yield$0.41 / 1.15%
Dividend Ex-Date11/29/2019
Dividend Pay-Date01/02/2020
Dividend Yield 5 Year AverageN/A
Next Earnings Announcement01/30/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$2.23
Beta vs. S&P 500N/A
Revenue$214.3 B
Net Profit Margin-0.28%
Return on Equity-7.92%

Analyst Ratings as of 11/10/2019

Buy
6
Overweight
0
Hold
12
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset